Clinical Research Directory
Browse clinical research sites, groups, and studies.
Preliminary Investigation of β-hydroxybutyrate Supplementation in Colorectal Cancer Prevention
Sponsor: Abramson Cancer Center at Penn Medicine
Summary
The aim of this study is to assess the feasibility of beta-hydroxybutyrate (BHB) supplementation in individuals who are undergoing a standard-of-care colonoscopy or flexible sigmoidoscopy.
Official title: Preliminary Investigation of β-hydroxybutyrate Supplementation in Colorectal Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2022-05-13
Completion Date
2026-06-30
Last Updated
2025-07-17
Healthy Volunteers
Yes
Conditions
Interventions
R-1,3-Butanediol
Study participants will be taking 35mL of HVMN Ketone-IQ by mouth three times daily, with each dose containing 10 grams of R-1,3-Butanediol.
Locations (1)
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States